An abbreviated new drug application (ANDA) contains data that is submitted to the USFDA for review and potential approval of a generic drug product.
Once approved, an applicant may manufacture and market the generic drug product to provide a safe, effective, lower cost alternative to the brand-name drug it references.
Dr. Reddy’s Laboratories Ltd. is an integrated pharmaceutical company headquartered in Hyderabad, Telangana, India. Its major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetes, oncology, pain management, and dermatology.
Dr. Reddy’s operates in markets across the globe. The company’s major markets include – USA, India, Russia, CIS countries, and Europe.